📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Mbd3/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program. (2017)

First Author: Loughran SJ
Attributed to:  The Oxford Single Cell Biology Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1084/jem.20161827

PubMed Identifier: 28899870

Publication URI: http://europepmc.org/abstract/MED/28899870

Type: Journal Article/Review

Volume: 214

Parent Publication: The Journal of experimental medicine

Issue: 10

ISSN: 0022-1007